{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:25:53Z","timestamp":1748359553206,"version":"3.37.3"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Mutations in the non-structural protein regions of hepatitis C virus (HCV) are a cause of a non-sustained virological response (SVR) to treatment with direct-acting antivirals (DAAs) for chronic hepatitis; however, there are non-SVR cases without these mutations. In this study, we examined immune cell profiles in peripheral blood before and after ombitasvir\/paritaprevir\/ritonavir treatment and screened for genes that could be used to predict the therapeutic effects of DAAs. Fluorescence-activated cell sorting analysis indicated that the median frequencies of programmed cell death-1-positive (PD-1+) effector regulatory T cells (eTregs), PD-1+CD8+ T cells, and PD-1+Helper T cells were decreased significantly in SVR cases, but without significant changes in non-SVR cases. The frequency of PD-1+ na\u00efve Tregs was significantly higher in the SVR group than in the non-SVR group before and after treatment. Similar results were found in patients treated with other DAAs (e.g., daclatasvir plus asunaprevir) and supported an immune response after HCV therapy. RNA-sequencing analysis indicated a significant increase in the expression of genes associated with the immune response in the SVR group, while genes related to intracellular and extracellular signal transduction were highly expressed in the non-SVR group. Therefore, we searched for genes associated with PD-1+ eTregs and CD8+ T cells that were significantly different between the SVR and non-SVR groups and found that T-box transcription factor 21 was associated with the non-SVR state. These results indicate that PD-1-related signaling pathways are associated with a non-SVR mechanism after DAAs treatment separate from mutation-related drug resistance.<\/jats:p>","DOI":"10.1371\/journal.pone.0299424","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T17:28:27Z","timestamp":1716485307000},"page":"e0299424","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy"],"prefix":"10.1371","volume":"19","author":[{"given":"Miyabi","family":"Miura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4927-1704","authenticated-orcid":true,"given":"Kazunori","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Shimakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikatsu","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriho","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Takatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3602-8086","authenticated-orcid":true,"given":"Tatsuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eishiro","family":"Mizukoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"issue":"5","key":"pone.0299424.ref001","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/jvh.13480","article-title":"Viral hepatitis C pandemic: Challenges and threats to its elimination","volume":"28","author":"L Krekulova","year":"2021","journal-title":"J Viral Hepat"},{"issue":"7262","key":"pone.0299424.ref002","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"D Ge","year":"2009","journal-title":"Nature"},{"issue":"10","key":"pone.0299424.ref003","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Y Tanaka","year":"2009","journal-title":"Nat Genet"},{"issue":"6","key":"pone.0299424.ref004","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/hep.27113","article-title":"Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection","volume":"59","author":"H Kumada","year":"2014","journal-title":"Hepatology"},{"issue":"13","key":"pone.0299424.ref005","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1080\/14656566.2021.1921737","article-title":"An update on direct antiviral agents for the treatment of hepatitis C.","volume":"22","author":"C Stanciu","year":"2021","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"pone.0299424.ref006","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hep.24724","article-title":"Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders","volume":"55","author":"K Chayama","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"pone.0299424.ref007","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2020.09.065","article-title":"Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside","volume":"160","author":"DC Rockey","year":"2021","journal-title":"Gastroenterology"},{"issue":"4","key":"pone.0299424.ref008","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.gtc.2015.07.005","article-title":"Impact of Hepatitis C Virus Infection on Hepatocellular Carcinoma.","volume":"44","author":"DM Tholey","year":"2015","journal-title":"Gastroenterol Clin North Am."},{"issue":"17","key":"pone.0299424.ref009","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174387","article-title":"Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma.","volume":"13","author":"M Borgia","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"1","key":"pone.0299424.ref010","doi-asserted-by":"crossref","first-page":"10624","DOI":"10.1038\/s41598-019-47024-8","article-title":"HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules.","volume":"9","author":"C Ackermann","year":"2019","journal-title":"Sci Rep."},{"key":"pone.0299424.ref011","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3389\/fimmu.2019.01926","article-title":"Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8(+) T-Cells in Advanced Liver Disease.","volume":"10","author":"A Vranjkovic","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"pone.0299424.ref012","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jhep.2021.03.004","article-title":"Treatment failure with DAA therapy: Importance of resistance","volume":"74","author":"C. Sarrazin","year":"2021","journal-title":"J Hepatol"},{"issue":"7","key":"pone.0299424.ref013","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/intimm\/dxm057","article-title":"PD-1 and PD-1 ligands: from discovery to clinical application","volume":"19","author":"T Okazaki","year":"2007","journal-title":"Int Immunol"},{"key":"pone.0299424.ref014","article-title":"The Liver-Immunity Nexus and Cancer Immunotherapy","author":"JC Lee","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"8","key":"pone.0299424.ref015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma.","volume":"18","author":"B Sangro","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"pone.0299424.ref016","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","article-title":"Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy","volume":"18","author":"MR Green","year":"2012","journal-title":"Clin Cancer Res"},{"key":"pone.0299424.ref017","doi-asserted-by":"crossref","first-page":"104368","DOI":"10.1016\/j.meegid.2020.104368","article-title":"The roles of programmed death ligand 1 in virus-associated cancers","volume":"84","author":"M Golrokh Mofrad","year":"2020","journal-title":"Infect Genet Evol"},{"issue":"1","key":"pone.0299424.ref018","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2018-02-833806","article-title":"Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?","volume":"132","author":"A Carbone","year":"2018","journal-title":"Blood"},{"issue":"6","key":"pone.0299424.ref019","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/JVI.02474-07","article-title":"High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.","volume":"82","author":"V Kasprowicz","year":"2008","journal-title":"J Virol"},{"issue":"3","key":"pone.0299424.ref020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1172\/JCI36604","article-title":"PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV","volume":"119","author":"D Franceschini","year":"2009","journal-title":"J Clin Invest"},{"issue":"11","key":"pone.0299424.ref021","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s40261-017-0565-5","article-title":"Safety and Efficacy of Ombitasvir\/Paritaprevir\/Ritonavir and Dasabuvir with or without Ribavirin for Treatment of Hepatitis C Virus Genotype 1: A Systematic Review and Meta-analysis.","volume":"37","author":"H Ahmed","year":"2017","journal-title":"Clin Drug Investig."},{"issue":"1","key":"pone.0299424.ref022","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S2468-1253(16)30080-2","article-title":"Management of hepatitis C virus infection in the Asia-Pacific region: an update","volume":"2","author":"SG Lim","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"pone.0299424.ref023","article-title":"Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis","author":"A Cui","year":"2023","journal-title":"J Hepatol"},{"issue":"9","key":"pone.0299424.ref024","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/eji.201646559","article-title":"Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.","volume":"46","author":"C Harmon","year":"2016","journal-title":"Eur J Immunol"},{"issue":"5","key":"pone.0299424.ref025","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.immuni.2020.03.020","article-title":"The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and Humans","volume":"52","author":"JL Johnson","year":"2020","journal-title":"Immunity"},{"issue":"7","key":"pone.0299424.ref026","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ni.2046","article-title":"Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection","volume":"12","author":"C Kao","year":"2011","journal-title":"Nat Immunol"},{"issue":"2","key":"pone.0299424.ref027","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2016.01.018","article-title":"Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses.","volume":"44","author":"A Taylor","year":"2016","journal-title":"Immunity"},{"issue":"2\u20133","key":"pone.0299424.ref028","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/tan.13458","article-title":"Impact of TBX21, GATA3, and FOXP3 gene polymorphisms on acute cellular rejection after liver transplantation","volume":"93","author":"H Thude","year":"2019","journal-title":"HLA"},{"issue":"19","key":"pone.0299424.ref029","article-title":"Alterations in Hepatocellular Carcinoma-Specific Immune Responses Following Hepatitis C Virus Elimination by Direct-Acting Antivirals.","volume":"23","author":"S Li","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"22","key":"pone.0299424.ref030","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1128\/JVI.01177-06","article-title":"PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion.","volume":"80","author":"S Urbani","year":"2006","journal-title":"J Virol"},{"issue":"46","key":"pone.0299424.ref031","doi-asserted-by":"crossref","first-page":"45785","DOI":"10.1074\/jbc.M307174200","article-title":"Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b","volume":"278","author":"S Boulant","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"pone.0299424.ref032","doi-asserted-by":"crossref","first-page":"e86567","DOI":"10.1371\/journal.pone.0086567","article-title":"Alternate reading frame protein (F protein) of hepatitis C virus: paradoxical effects of activation and apoptosis on human dendritic cells lead to stimulation of T cells.","volume":"9","author":"SK Samrat","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"pone.0299424.ref033","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s10753-015-0160-y","article-title":"Potential Role of Hepatitis C Virus Alternate Reading Frame Protein in Negative Regulation of T-Bet Gene Expression","volume":"38","author":"DY Zhu","year":"2015","journal-title":"Inflammation"},{"issue":"5","key":"pone.0299424.ref034","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00705-018-3750-9","article-title":"Association of IL-28B, TBX21 gene polymorphisms and predictors of virological response for chronic hepatitis C","volume":"163","author":"DY Zhu","year":"2018","journal-title":"Arch Virol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0299424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T17:28:59Z","timestamp":1716485339000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0299424"}},"subtitle":[],"editor":[{"given":"Yury E.","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0299424","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2024,5,23]]}}}